|
Normal control group
|
136.5 ± 18.52
|
121.33 ± 12.08
|
119.25 ± 11.35
|
109 ± 10.92
|
|
Diabetic control group
|
359.75 ± 45.13*
|
328 ± 141.34*
|
428.5 ± 121.17*
|
396.5 ± 80.60*
|
|
Diabetic group treated with bromocriptine
|
191 ± 16.89#
|
199.25 ± 65.05#
|
238.25 ± 56.88#
|
284.25 ± 148.00#
|
|
Diabetic group treated with Cabergoline
|
213.75 ± 37.74#
|
211.75 ± 38.62#
|
293 ± 213.15#
|
280.25 ± 220.48#
|
|
Diabetic group treated with sarpogrelate
|
326.25 ± 93.45
|
298.25 ± 122.37
|
393.75 ± 118.77
|
369.75 ± 43.15
|
|
Diabetic group treated with bromocriptine + sarpogrelate
|
247.75 ± 50.35#
|
215.5 ± 33.20#
|
310.25 ± 70.59#
|
288.25 ± 109.41#
|
|
Diabetic group treated with cabergoline + sarpogrelate
|
196 ± 54.20#
|
158.75 ± 35.01#
|
235.5 ± 182.22#
|
215.75 ± 141.46#
|
